Responses
Clinical/translational cancer immunotherapy
Original research
Avelumab for platinum-ineligible/refractory recurrent and/or metastatic squamous cell carcinoma of the head and neck: phase Ib results from the JAVELIN Solid Tumor trial
Compose a Response to This Article
Other responses
No responses have been published for this article.
